Vern Schramm's guest appearances

Vern Schramm

Einstein On...

Einstein-Montefiore Institute for Clinical and Translational Research

Allen M. Spiegel

Dan Kelly

Paul Frenette

Nir Barzilai

David Goldman

Mina Bissell

Keith Ayoob

Arturo Casadevall

Joseph Crowley

John Foxe

Nancy Bennett

Jeffrey Pessin

Harry Ostrer

Richard Lipton

Roy Chuck

OwlTail

http://www.einstein.yu.edu - Vern Schramm, Ph.D., professor and chair of biochemistry, discusses how Einstein’s proposed Center for Molecular Therapeutics and Drug Discovery will help propel research findings into clinical applications. This will be crucial for drug therapies that large drug companies do not typically invest in, such as those for tuberculosis and malaria. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs

<a href="http://www.einstein.yu.edu" rel="nofollow" target="_blank">http://www.einstein.yu.edu</a> - Vern Schramm, Ph.D., professor and chair of biochemistry, discusses how Einstein’s proposed Center for Molecular Therapeutics and Drug Discovery will help propel research findings into clinical applications. This will be crucial for drug therapies that large drug companies do not typically invest in, such as those for tuberculosis and malaria. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs

Einstein On: Drug Discovery, Dr. Vern Schramm (2 of 2): Center for Molecular Therapeutics and Drug Discovery

http://www.einstein.yu.edu - Vern Schramm, Ph.D., professor and chair of biochemistry at Einstein, discusses drug development for a wide range of diseases -- including T-cell leukemia, gout, malaria and autoimmune disorders -- based on his research in transition state analogues. Dr. Schramm, who holds the Ruth Mearns Chair in Biochemistry, also talks about his childhood in South Dakota and what influenced him to become interested in chemistry. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs.

<a href="http://www.einstein.yu.edu" rel="nofollow" target="_blank">http://www.einstein.yu.edu</a> - Vern Schramm, Ph.D., professor and chair of biochemistry at Einstein, discusses drug development for a wide range of diseases -- including T-cell leukemia, gout, malaria and autoimmune disorders -- based on his research in transition state analogues. Dr. Schramm, who holds the Ruth Mearns Chair in Biochemistry, also talks about his childhood in South Dakota and what influenced him to become interested in chemistry. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs.

Einstein On: Drug Discovery, Dr. Vern Schramm (1 of 2): Transition State Enzymes

Vern Schramm, Ph.D. presents "Transition State Therapeutics: Cancer and Beyond" at the "Bridging the Translational Divides" symposium hosted by the Einstein-Montefiore Institute for Clinical and Translational Research. Dr. Schramm is professor and Ruth Merns Chair of biochemistry at Einstein.

Vern Schramm, Ph.D., on Transition State Therapeutics